Below is a list of forthcoming submissions that have recently been added to the SMC's work programme.

• Adapalene (Epiduo Gel)
• Aflibercept (Eylea)
• Alemtuzumab (Lemtrada)
• Azithromycin (Zedbec)
• Canagliflozin hemihydrate (Invokana)
• Certolizumab pegol (Cimzia)
• Emtricitabine with rilpivirine hydrochloride and tenofovir (Eviplera)
• Fluticasone furoate with vilanterol (Relvar)
• Lenalidomide (Revlimid)
• Macitentan (Opsumit)

For more details, go to: http://www.scottishmedicines.org.uk/SMC_Advice/Forthcoming_Submissions/Forthcoming_Submissions?iru=2...